| a7nAChR | alpha-7 nicotinic acetylcholine receptor |
| ABCA1 | ATP binding cassette A1 |
| ABCB1 | ATP-binding cassette sub-family B member 1 |
| ACE | Angiotensin-converting enzyme |
| AD | Alzheimer’s disease |
| AJ | Adherent-junction |
| ApoE | Apolipoprotein E |
| APP | Amyloid precursor protein |
| AQP4 | Aquaporin-4 water channels |
| ARB | Angiotensin receptor blocker |
| AT1 | Angiotensin II type 1 receptor |
| Aβ | Amyloid β-peptide |
| BACE1 | Beta-site APP cleaving enzyme 1 |
| BBB | Blood-brain barrier |
| BDNF | Brain-derived neurotrophic factor |
| BEC | Brain endothelial cell |
| b-FGF | Basic fibroblast growth factor |
| C.p. | Clinical phase |
| Cx | Complement factors |
| CAA | Cerebral amyloid angiopathy |
| CBF | Cerebral blood flow |
| CCB | Calcium channel blocker |
| CNS | Central nervous system |
| COX-2 | Cyclooxygenase-2 |
| CR | Complement receptor |
| CSF | Cerebrospinal fluid |
| DDS | Drug delivery systems |
| eNOS | Endothelial nitric oxide synthase |
| fAβ | Fibrillar Aβ |
| Fc γ R | Fc γ receptor |
| Fyn | Proto-oncogene tyrosine-protein kinase Fyn |
| GDNF | Glial cell-derived neurotrophic factor |
| GLP-1 | Glucagon-like peptide 1 |
| GLUT | Glucose transporter |
| GSK3β | Glycogen synthase kinase 3β |
| HCHWA-D | Hereditary cerebral hemorrhage with amyloidosis-Dutch type |
| HImAb | Human insulin mAb |
| HMG-CoA | 3-Hydroxy-3-methylglutaryl-CoA |
| HSA | Human serum albumin |
| IEL | Internal elastic lamina |
| IGF-1 | Insulin-like growth factor 1 |
| IgG | Immunoglobulin G |
| IL-1α | Interleukin-1 alpha |
| IL-1 β | Interleukin-1 beta |
| IL-1R1 | Interleukin 1 receptor type 1 |
| iNos | inducible nitric oxide synthase |
| IR | Insulin receptor |
| ISF | Interstitial fluid |
| LAMs | Leukocyte adhesion molecules |
| LRP1 | Low-density lipoprotein receptor-related protein 1 |
| mAb | Monoclonal antibody |
| mAβ | Monomeric Aβ |
| MEOX2 | Mesenchyme homeobox gene 2 |
| MMP | Matrix metalloproteinase |
| MTJ | Molecular Trojan horse |
| NF-kB | Nuclear factor-κB |
| NFT | Neurofibrillary tangle |
| NGF | Nerve growth factor |
| NMDAR | N-Methyl-d-aspartate receptors |
| NP | Neuritic plaque |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| NVU | Neurovascular unit |
| oAβ | Oligomeric Aβ |
| p47PHOX | Neutrophil cytosol factor 1 |
| Pcp | Preclinical phase |
| PDGF-B | Platelet-derived growth factor subunit B |
| PDGFRβ | Platelet-derived growth factor receptor-β |
| PGE2 | Prostaglandin-E2 |
| P-gp | P-glycoprotein |
| PHF | Paired helical filament |
| PI3K | Phosphatidylinositol 3-kinase |
| PVMs | Perivascular macrophages |
| RAGE | Receptor for advanced glycation endproducts |
| RMT | Receptor-mediated transcytosis |
| ROS | Reactive oxygen species |
| sAPPα | Secreted ectodomain APP alpha |
| SAS | Subarachnoid space |
| SEC-R | Serpin-enzyme complex receptor |
| sLRP | Soluble low-density lipoprotein receptor-related protein |
| SMC | Smooth muscle cell |
| SRA | Class A scavenger receptor |
| SRB2 | Scavenger receptor class B member 2 |
| SREBP2 | Sterol response element-binding protein 2 |
| SRF | Serum response factor |
| TfR | Human transferrin receptor |
| TGF-β | Transforming growth factor-beta |
| TJ | Tight-junction |
| TLR | Toll-like receptor |
| TNF-α | Tumoral necrosis factor-α |
| TNFR | Tumoral necrosis factor receptor |
| TREM2 | Triggering receptor expressed on myeloid cells 2 |
| VEGF | Vascular endothelial growth factor |
| ZO-1 | Zonula occludens-1 |
| γ-PPAR | Peroxisome proliferator-activated receptor-γ |